Your browser doesn't support javascript.
loading
Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT).
Huntgeburth, Michael; Kießling, Johannes; Weimann, Gerrit; Wilberg, Verena; Saleh, Soundos; Hunzelmann, Nicolas; Rosenkranz, Stephan.
Afiliação
  • Huntgeburth M; Clinic III for Internal Medicine, Department of Cardiology, Heart Center, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Kießling J; Clinic III for Internal Medicine, Department of Cardiology, Heart Center, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany.
  • Weimann G; Bayer AG, Berlin, Germany.
  • Wilberg V; ClinStat GmbH, Cologne, Germany.
  • Saleh S; Bayer AG, Berlin, Germany.
  • Hunzelmann N; Department of Dermatology, University of Cologne, Cologne, Germany.
  • Rosenkranz S; Clinic III for Internal Medicine, Department of Cardiology, Heart Center, University Hospital of Cologne, Kerpener Str. 62, 50937, Cologne, Germany. stephan.rosenkranz@uk-koeln.de.
Clin Drug Investig ; 38(11): 1061-1069, 2018 Nov.
Article em En | MEDLINE | ID: mdl-30238433
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Doença de Raynaud / Velocidade do Fluxo Sanguíneo / Ativadores de Enzimas / Dedos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Pirimidinas / Doença de Raynaud / Velocidade do Fluxo Sanguíneo / Ativadores de Enzimas / Dedos Tipo de estudo: Clinical_trials / Diagnostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article